C. James Chou
About C. James Chou
C. James Chou is a Senior Director at mProbe and an Affiliated Associate Professor at the Medical University of South Carolina. He has extensive experience in drug discovery and translational medicine, with a focus on cancer, immunological, and neurological diseases.
Work at mProbe Inc.
C. James Chou serves as Senior Director at mProbe Inc. since 2021. The company is located in Palo Alto, California, and focuses on innovative solutions in the medical field. In this role, Chou applies his extensive knowledge in drug discovery and translational medicine to advance the company's objectives.
Current Academic Roles
Chou holds the position of Affiliated Associate Professor at the Medical University of South Carolina since 2021. He also serves as a Visiting Scholar at Stanford University starting in 2022. These roles allow him to engage in academic research and collaboration within the fields of cancer, immunological, and neurological diseases.
Co-Founder of Neuroene Therapeutics
Since 2015, Chou has been a Co-Founder of Neuroene Therapeutics, based in Washington, District of Columbia. This organization focuses on developing therapeutic solutions, leveraging his expertise in drug discovery and translational medicine.
Education and Expertise
Chou earned a Doctor of Philosophy (Ph.D.) in Medicinal, Pharmaceutical, and Biological Chemistry from the University of Washington, studying from 1999 to 2004. He also holds a Bachelor of Arts (B.A.) in Economics and a Bachelor of Science (B.S.) in Biochemistry, both from the University of Washington, completed between 1993 and 1998. His educational background supports his strong expertise in molecular and cellular biology and bio-conjugation techniques.
Previous Positions
Chou has held various academic positions at the Medical University of South Carolina, including Associate Professor from 2009 to 2021 and Assistant Professor from 2009 to 2016. He also worked as a Postdoctoral Fellow at Scripps Research from 2004 to 2009. These roles contributed to his extensive experience in therapeutic research.